Literature DB >> 17141252

Determination of propiverine and its metabolites in rat samples by liquid chromatography-tandem mass spectrometry.

R Oertel1, B Kilian, W Siegmund, W Kirch.   

Abstract

A liquid chromatography-tandem mass spectrometric (LC-MS-MS) method was developed and validated for the determination of the anticholinergic and antimuscarinc drug propiverine and eight of its metabolites in serum, urine, faeces and different tissue samples of rats. Samples containing propiverine and its metabolites in serum and urine and in the supernatants of faeces and tissue homogenates were extracted and cleaned up using an automated solid phase extraction (SPE) method. An external calibration was used. The analytes were measured employing the multiple reaction monitoring mode (MRM). A sufficient response over the range of 10-1000 ng/ml was demonstrated. The lower limit of quantification of the nine substances was 10 ng/ml. The presented method is suitable for pharmacokinetic or toxicokinetic studies. To look for additional unknown metabolites, the LC-MS-MS system operated in the precursor ion mode using typical product ions of propiverine and of its metabolites. With the help of the chromatographic behaviour and typical fragment ions of the unknown metabolites, it was possible to elucidate their structure. Five until now unknown metabolites were found in the urine and faeces samples. However, without reference substances, a quantification of these analytes was not possible.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141252     DOI: 10.1016/j.chroma.2006.11.021

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  3 in total

1.  Metabolism profile of quinocetone in swine by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry.

Authors:  Haixia Wu; Chunyan Yang; Zhanhui Wang; Jianzhong Shen; Suxia Zhang; Peisheng Feng; Linxia Li; Linli Cheng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-09-20       Impact factor: 2.441

2.  Pharmacokinetics and pharmacodynamics of propiverine in children aged between 5 and 10 years with symptoms of overactive bladder.

Authors:  Werner Siegmund; Ulla Sillén; Göran Läckgren; Frieder Schnabel; Gerd Mürtz; Cornelia Feustel
Journal:  Clin Pharmacokinet       Date:  2010-05       Impact factor: 6.447

3.  Oral absorption of propiverine solution and of the immediate and extended release dosage forms: influence of regioselective intestinal elimination.

Authors:  Karen May; Thomas Giessmann; Danilo Wegner; Reinhard Oertel; Christiane Modess; Stefan Oswald; Manfred Braeter; Werner Siegmund
Journal:  Eur J Clin Pharmacol       Date:  2008-07-15       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.